Related Experiment Video
Updated: Aug 12, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Adenosine preconditions against endothelin-induced constriction of coronary arterioles
D Merkus1, D W Stepp, D W Jones
1Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA. dmerkus@mcw.edu
Insights
Adenosine preconditioning, through A(2) receptors, protects against endothelin-1 induced coronary artery constriction. This vascular preconditioning effect may prevent excessive vasoconstriction during myocardial hypoperfusion.
Area of Science:
- Cardiovascular Physiology
- Vascular Biology
- Pharmacology
Background:
- Myocardial hypoperfusion increases adenosine and endothelin-1 (ET-1).
- Adenosine's vasodilatory effect typically outweighs ET-1's vasoconstriction.
- The interaction between adenosine and ET-1 during preconditioning is not fully understood.
Purpose of the Study:
- To investigate if adenosine-induced or ischemic preconditioning reduces the vasoconstrictive effect of ET-1.
- To identify the specific adenosine receptor subtype involved in this protective mechanism.
Main Methods:
- Coronary arteriolar diameter was measured in vivo using fluorescence microangiography in dogs.
- Isolated coronary arterioles were used in vitro to assess ET-1 dose-response curves.
- Adenosine and specific A(1) or A(2) receptor antagonists were administered to evaluate their effects.
Main Results:
- ET-1 induced significant coronary constriction in vivo.
- Adenosine preconditioning completely blocked ET-1-induced constriction.
- Ischemic preconditioning attenuated ET-1-induced constriction.
- Adenosine preconditioning shifted the ET-1 dose-response curve rightward, an effect blocked by A(2) receptor antagonists but not A(1) antagonists.
Conclusions:
- Adenosine confers a vascular preconditioning effect against endothelin-1-induced coronary constriction.
- This protective effect is mediated via the A(2) adenosine receptor.
- Adenosine's role in preventing excessive coronary constriction may be a novel protective mechanism.
Abstract:
Myocardial hypoperfusion is accompanied by concomitant increases in adenosine and endothelin-1 (ET-1) production, but the vasodilatory effect of adenosine prevails over that of ET-1. Therefore, we hypothesized that adenosine-induced or ischemic preconditioning reduces the vasoconstrictive effect of ET-1. Coronary arteriolar diameter in vivo was measured using fluorescence microangiography in anesthetized open-thorax dogs. ET-1 (5 ng. kg(-1). min(-1) administered intracoronary, n = 10) induced progressive constriction over 45 min [25 +/- 6% (SE)]. The constriction was blocked by preconditioning with adenosine (25 microgram. kg(-1). min(-1) administered intracoronary) for 20 min and 10 min of washout (n = 10) or attenuated by ischemic preconditioning (four 5-min periods of ischemia, 9 +/- 5% at 45 min). To investigate the receptor involved in this process, coronary arterioles (50-150 micrometer) were isolated and pressurized at 60 mmHg in vitro. The ET-1 dose-response curve (1 pM-5 nM) was rightward shifted after preconditioning with adenosine (1 microM) for 20 min and 10 min of washout (n = 11). Blockade of A(2) receptors [8-(3-chlorostyryl)caffeine, 1 microM, n = 9] but not A(1) receptors (8-cyclopentyl-1,3-dipropylxanthine, 100 nM, n = 7) prevented this shift. These results suggest that adenosine confers a vascular preconditioning effect, mediated via the A(2) receptor, against endothelin-induced constriction. This effect may offer a new protective function of adenosine in preventing excessive coronary constriction.
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Vasodilators
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...

